Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Herpes encephalitis in Hodgkin's disease].
Heinz R, Fortelny A, Waldner R, Grisold W, Jellinger K. Heinz R, et al. Among authors: fortelny a. Dtsch Med Wochenschr. 1986 May 30;111(22):881-2. Dtsch Med Wochenschr. 1986. PMID: 3709364 German. No abstract available.
[Erythropoietin in multiple myeloma].
Pecherstorfer M, Schmoranzer F, Vesely M, Fortelny A, Baumgartner G. Pecherstorfer M, et al. Among authors: fortelny a. Dtsch Med Wochenschr. 1990 Jul 13;115(28-29):1096-9. doi: 10.1055/s-2008-1065126. Dtsch Med Wochenschr. 1990. PMID: 2373040 German.
MACOP-B treatment in patients with Ki-1-positive large-cell anaplastic lymphoma.
Marosi C, Heinz R, Steger G, Fortelny A, Chott A, Hanak H, Radaszkiewicz T, Baur M, Kreiner G, Schwarzinger I, et al. Marosi C, et al. Among authors: fortelny a. J Cancer Res Clin Oncol. 1992;118(4):314-7. doi: 10.1007/BF01208622. J Cancer Res Clin Oncol. 1992. PMID: 1374411 Clinical Trial.
[Pamidronate in the treatment of tumor-associated hypercalcemia].
Pecherstorfer M, Janisch S, Marosi C, Wogritsch C, Bosse C, Schratzberger W, Gerber E, Fortelny A, Lenzhofer R, Rainer H, et al. Pecherstorfer M, et al. Among authors: fortelny a. Klin Wochenschr. 1991 Oct 2;69(15):690-5. doi: 10.1007/BF01649438. Klin Wochenschr. 1991. PMID: 1795492 Clinical Trial. German.
Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer.
Gnant M, Fitzal F, Rinnerthaler G, Steger GG, Greil-Ressler S, Balic M, Heck D, Jakesz R, Thaler J, Egle D, Manfreda D, Bjelic-Radisic V, Wieder U, Singer CF, Melbinger-Zeinitzer E, Haslbauer F, Sevelda P, Trapl H, Wette V, Wimmer K, Gampenrieder SP, Bartsch R, Kacerovsky-Strobl S, Suppan C, Brunner C, Deutschmann C, Soelkner L, Fesl C, Greil R; Austrian Breast and Colorectal Cancer Study Group. Gnant M, et al. N Engl J Med. 2021 Jul 29;385(5):395-405. doi: 10.1056/NEJMoa2104162. N Engl J Med. 2021. PMID: 34320285 Clinical Trial.
The Austrian fulvestrant registry: results from a prospective observation of fulvestrant in postmenopausal patients with metastatic breast cancer.
Bartsch R, Mlineritsch B, Gnant M, Niernberger T, Pluschnig U, Greil R, Wenzel C, Sevelda P, Thaler J, Rudas M, Pober M, Zielinski CC, Steger GG; Austrian Fulvestrant Registry. Bartsch R, et al. Breast Cancer Res Treat. 2009 May;115(2):373-80. doi: 10.1007/s10549-008-0132-0. Epub 2008 Jul 26. Breast Cancer Res Treat. 2009. PMID: 18661231 Clinical Trial.